Cargando…

CD40 is Positively Correlated with the Expression of Nucleophosmin in Cisplatin-Resistant Bladder Cancer

OBJECTIVE: To verify and evaluate the value of CD40 as a noninvasive biomarker of cisplatin-resistant bladder cancer, we studied the expression of CD40 and the correlation between nucleophosmin (NPM1) and CD40 in cisplatin-resistant bladder cancer. METHODS: Three cisplatin-resistant bladder cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Chenshuo, Lei, Ting, Zhao, Man, Meng, Qian, Zhang, Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204159/ https://www.ncbi.nlm.nih.gov/pubmed/32411234 http://dx.doi.org/10.1155/2020/3676751

Ejemplares similares

CD133-regulated nucleophosmin expression in human colon cancer cells
por: Kim, Kun, et al.
Publicado: (2014)

Expression of Nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells
por: Liu, Yan, et al.
Publicado: (2012)

Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters
por: Yun, J-P, et al.
Publicado: (2007)

Knockdown of ferritin heavy chain (FTH) inhibits the migration of prostate cancer through reducing S100A4, S100A2, and S100P expression
por: Lu, Cuixiu, et al.
Publicado: (2020)

Extracellular Nucleophosmin Is Increased in Psoriasis and Correlates With the Determinants of Cardiovascular Diseases
por: D'Agostino, Marco, et al.
Publicado: (2022)

Phosphorylation of Nucleophosmin at Threonine 234/237 is associated with HCC metastasis
por: Ha Ching, Rachel Hiu, et al.
Publicado: (2015)

NUCLEOPHOSMIN MUTATION IS DOUBLE TROUBLE
por: Robinson, Richard
Publicado: (2008)

Nucleophosmin in Its Interaction with Ligands
por: Cela, Ilaria, et al.
Publicado: (2020)

Targeting immunotherapy for bladder cancer by using anti-CD3 × CD155 bispecific antibody
por: Ma, Wanru, et al.
Publicado: (2019)

Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer
por: Jiang, Xue, et al.
Publicado: (2018)

Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications
por: Leal, Mariana Ferreira, et al.
Publicado: (2014)

Molecules that target nucleophosmin for cancer treatment: an update
por: Di Matteo, Adele, et al.
Publicado: (2016)

Nucleophosmin: from structure and function to disease development
por: Box, Joseph K., et al.
Publicado: (2016)

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
por: Zarka, Jabra, et al.
Publicado: (2020)

Chromatin localization of nucleophosmin organizes ribosome biogenesis
por: Ugolini, Ilaria, et al.
Publicado: (2022)

YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer
por: Su, Yinjie, et al.
Publicado: (2023)

Targeting immunotherapy for bladder cancer using anti‐CD3× B7‐H3 bispecific antibody
por: Ma, Wanru, et al.
Publicado: (2018)

Structural Consequences of Nucleophosmin Mutations in Acute Myeloid Leukemia
por: Grummitt, Charles G., et al.
Publicado: (2008)

Regulation of subcellular distribution and oncogenic potential of nucleophosmin by plakoglobin
por: Lam, L, et al.
Publicado: (2012)

Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma
por: LIU, MEI, et al.
Publicado: (2015)

The function of DNA binding protein nucleophosmin in AAV replication
por: Satkunanathan, Stifani, et al.
Publicado: (2017)

Quantitative Assay of Mutated Nucleophosmin in Acute Myeloid Leukemia
por: Khaled, Safaa A.A., et al.
Publicado: (2019)

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
por: Šašinková, Markéta, et al.
Publicado: (2021)

Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1
por: Florio, Daniele, et al.
Publicado: (2022)

The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer
por: Wang, Shanshan, et al.
Publicado: (2016)

Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells
por: Wang, Shanshan, et al.
Publicado: (2017)

Nucleolin and nucleophosmin expression patterns in pulmonary adenocarcinoma invading the pleura and in pleural malignant mesothelioma
por: Masiuk, Marek, et al.
Publicado: (2020)

Playing both sides: nucleophosmin between tumor suppression and oncogenesis
por: Di Fiore, Pier Paolo
Publicado: (2008)

Hijacking ZIP codes: posttanscriptional regulation of CCN2 by nucleophosmin
por: Leask, Andrew
Publicado: (2009)

GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer
por: Kim, Jee-Youn, et al.
Publicado: (2015)

A redox mechanism underlying nucleolar stress sensing by nucleophosmin
por: Yang, Kai, et al.
Publicado: (2016)

Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemia
por: Urbaneja, María A., et al.
Publicado: (2017)

Analysis of the oligomeric states of nucleophosmin using size exclusion chromatography
por: Sakashita, Gyosuke, et al.
Publicado: (2018)

Role of Nucleophosmin Gene Mutation in Leukemogenesis of Acute Myeloid Leukemia
por: Khaled, Safaa A.A., et al.
Publicado: (2018)

Puf-A promotes cancer progression by interacting with nucleophosmin in nucleolus
por: Cho, Huan-Chieh, et al.
Publicado: (2022)

Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance
por: Lee, Min Young, et al.
Publicado: (2018)

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
por: Shi, Zhen-duo, et al.
Publicado: (2022)

Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia
por: Kuželová, Kateřina, et al.
Publicado: (2015)

FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer
por: Lu, Yi-Tsung, et al.
Publicado: (2022)

MMP9 Expression Correlates With Cisplatin Resistance in Small Cell Lung Cancer Patients
por: Wu, Longqiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5985ipo4vqm0668ufi3q5u3ecf